Searched for
CORBEVAX VACCINE
100 million doses of Corbevax supplied to Centre: Biological E LtdIn a release, the city-based vaccine maker said, "Biological E. Limited has delivered 10 crore doses of Corbevax to the Government of India...- Vaccinated with Covaxin or Covishield? You may take Corbevax as precaution doseThe government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield o...
- Health Ministry likely to approve Corbevax as booster for adults vaccinated with Covishield, Covaxin"Corbevax will be considered as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second do...
- NTAGI has found Corbevax efficient as a booster, govt may soon recommend it: Drug Controller General of IndiaThe National Technical Advisory Group on Immunisation (NTAGI) which reviewed the data of Corbevax earlier had found significant antibody re...
- Govt panel recommends Corbevax as booster for adults vaccinated with Covishield, CovaxinThe COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) made the recommendation in its 48th meeting hel...
- 'Corbevax under WHO's detailed review for emergency use listing'The WHO website states that the rolling data submission has begun on June 10 and the decision date on EUL is yet to be confirmed. The compa...
- NTAGI's STSC recommends use of Covaxin, Corbevax for children aged 5-12The Corbevax vaccine has been recommended for 5-12 years old, meanwhile, Covaxin will be used for children aged 6-12 years.
- NTAGI to decide on including Corbevax as a booster dose in inoculation drive"We will review the data of Corbevax in our next meeting slated to happen this month and evaluate if mix and match of vaccines can be allow...
- Corbevax may soon get nod to be used as fresh boosterIndia's drug regulator on Saturday granted approval to Hyderabad-based Biological E's Covid-19 vaccine Corbevax to be allowed as a booster ...
- Corbevax gets DCGI nod as heterologous Covid booster dose for adultsThe vaccine can be administered after 6 months of administration of primary vaccination (two doses) of Covaxin or Covishield vaccines for r...
- Biological E. cuts price of its COVID-19 vaccine to Rs 250 per doseIt would result in end users paying a price of Rs 400 a dose, including taxes and administration charges, the company said in a statement. ...
- COVID-19: Government to expedite process of recognition of Biological E Corbevax by other countries"It is necessary to quickly initiate the process of recognition of the Corbevax vaccine and its certificate by other countries while Biolog...
- Corbevax vaccine to cost Rs 990 in market, Rs 145 for governmentBiological E said that it is providing the most affordable Covid vaccine on a global scale due to process of innovation, large-scale manufa...
- COVID-19 vaccination for children aged 12-14 starts todayThe inoculation of children in the age group of 12 to 14 years against COVID-19 started on Wednesday with Corbevax vaccine. Besides, the go...
- Govt releases guidelines for Covid vaccination of children in 12-14 years age groupCOVID-19 vaccination of children between 12-14 years will begin from March 16 and only Corbevax vaccine would be used for the beneficiaries...
- Corbevax suggested for pregnant womenThe company had started manufacturing in December and is expected to supply 50 million doses of the vaccine to the government this month.
- Biological E seeks EUA for its Corbevax vaccine for 12-18 yrs age groupThe Drugs Controller General Of India (DCGI) has already approved Corbevax, which is India's first indigenously developed RBD protein sub-u...
- Centre places purchase order for 5 cr doses of Corbevax Covid vaccine each costing Rs 145 sans taxThe government is yet to decide on which segment of beneficiaries this new vaccine would be administered.
- Biological E gets nod for phase 2/3 clinical trial of its Covid vaccine on children above 5 years, adolescentsThe approval for conducting phase III comparator safety and immunogenicity trial in adults came after the SEC's review of Phase I and II cl...
- Dynavax to supply its CpG 1018 adjuvant for Biological E's COVID-19 Vaccine CandidatePending conditional regulatory approvals in India, BE expects to commence product launch of Corbevax later this year.
Load More
